Dr. Fearon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1998 - 2001
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1994 - 1997
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1994
Certifications & Licensure
- CA State Medical License 1995 - 2025
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Join now to see all
Clinical Trials
- Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy Start of enrollment: 2009 Jun 01
- A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease Start of enrollment: 2014 Aug 25
- CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?) Start of enrollment: 2014 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsPractical Application of Coronary Physiologic Assessment: Asia-Pacific Expert Consensus Document: Part 1.Bon-Kwon Koo, Joo Myung Lee, Doyeon Hwang, Sungjoon Park, Yasutsugu Shiono
JACC. Asia. 2023-10-01 - 153 citationsAngiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.Bo Xu, Shengxian Tu, Lei Song, Zening Jin, Bo Yu
Lancet. 2021-11-04 - 761 citationsFractional Flow Reserve–Guided PCI for Stable Coronary Artery DiseaseBernard De Bruyne, William F. Fearon, Nico H.J. Pijls, Emanuele Barbato, Pim A.L. Tonino
The New England Journal of Medicine. 2014-09-24
Journal Articles
- Association of Endothelin-1 with Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart TransplantationKiran Khush, Alan C Yeung, Hannah Valantine, William F Fearon, Journal of Cardiac Failure
- Original Investigation High Coronary Shear Stress in Patients with Coronary Artery Disease Predicts Myocardial InfarctionDaniel Molloy, Hossein Hosseini, Habib Samady, Karthic Chandran, William F Fearon, Nikita Chand, ScienceDirect
- Clinical Research Sex Differences in Adenosine-Free Coronary Pressure Indexes: A CONTRAST SubstudyNils P Johnson, William F Fearon, Allen Jeremias, ScienceDirect
- Join now to see all
Lectures
- Pathophysiology of the Coronary Circulation in STEMI and NSTEMICRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- FFRangio Compared to FFR – Clinical Data and Subgroup MVD AnalysisCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Why Bother With 2 Stents? Just iFR or FFR the Ostial Circumflex2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Authored Content
- Fractional Flow Reserve and “Hard” EndpointsJune 2020
- Fractional Flow Reserve and “Hard” EndpointsJune 2020
- Focus on Coronary Physiology Assessment in Special Cohorts Editorial Comment Predicting Outcomes After Percutaneous Coronary Intervention Using Relative Change in Fractional Flow Reserve∗October 2018
- Long-Term Prognostic Value of Invasive and Non-Invasive Measures Early After Heart TransplantationApril 2018
- Long-Term Prognostic Value of Invasive and Non-Invasive Measures Early After Heart TransplantationApril 2018
- Join now to see all
Press Mentions
- FAME 3 Subanalysis Adds Twist to Negative Primary ResultsApril 3rd, 2022
- No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3April 2nd, 2022
- FFR’s Future: Negative Trials Spur Debate over Technology’s RoleDecember 23rd, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: